Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2021-09-30 01:30Coherus BioSciences Mourns the Passing of Board Member Dr. Samuel Nussbaum and more...
2021-09-29 01:30Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021 and more...
2021-09-28 01:30Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences and more...
2021-09-27 01:30Innovent and AnHeart Announce Interim Data from Phase 2 Trial of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting and more...
2021-09-25 01:30Catalyst Biosciences to Present at the Cantor Global Healthcare Conference and more...
2021-09-24 01:30Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources and more...
2021-09-23 01:30Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Therapy for Esophageal Squamous Cell Carcinoma (ESCC) and more...
2021-09-22 01:30Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference and more...
2021-09-21 01:30Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer and more...
2021-09-18 01:30Bay Area biotechs soar on coattails of AstraZeneca cancer drug study and more...
2021-09-17 01:30Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021 and more...
2021-09-16 01:30Rezolute Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results and Highlights Recent Company Progress and more...
2021-09-15 01:30Nkarta to Participate at Upcoming Investor Conference and more...
2021-09-14 01:30Cancer Immunologist Karin Pelka Joins Gladstone Institutes and more...
2021-09-12 01:30CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021 and more...
2021-09-11 01:30BioEclipse Therapeutics™ to Present at Virtual H.C. Wainwright 23rd Annual Global Healthcare Conference and more...
2021-09-10 01:30Dynavax to Present at the H.C. Wainwright 23rd Annual Global Investment Conference and more...
2021-09-09 01:30Engineers pursue novel way to tackle some of today’s hardest computations and more...
2021-09-08 01:30Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China and more...
2021-09-07 01:30U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings
2021-09-06 01:30SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline – ARDX
2021-09-05 01:30Abrupt FDA exits spark concern; Unpacking key concepts at gene therapy summit; 20 luminaries who reshaped R&D; and more
2021-09-04 01:30RAPT Therapeutics to Present at Upcoming Investor Conferences and more...
2021-09-03 01:30Cytek Biosciences Reports Second Quarter 2021 Financial Results and more...
2021-09-02 01:30Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor) and more...
2021-09-01 01:30Bay Area Council backs Covid-19 vaccine requirements for the private sector and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語